Prevention of intrathecal drug delivery catheter-related complications

Neuromodulation

Volumn 6, Issue 1, 2003, Pages 32-41

  Follett, Kenneth A ^a   Burchiel, Kim ^b   Deer, Timothy ^c   DuPen, Stuart ^d   Prager, Joshua ^e   Turner, Michael S ^f   Coffey, Robert J ^g  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Center for Pain Relief   (United States)

^d SWEDISH MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Indianapolis Neurosurgical Group   (United States)

^g MEDTRONIC INC   (United States)

Author keywords

Drug administration system; Intrathecal catheter; Intrathecal drug delivery; Pain; Pump; Spasticity

Indexed keywords

ANTIBIOTIC AGENT;

ANESTHESIST; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CATHETER; CLINICAL STUDY; DISEASE ASSOCIATION; HUMAN; INFUSION PUMP; INTRATHECAL DRUG ADMINISTRATION; MEDICAL SPECIALIST; PERFORMANCE; PHYSICIAN; POSTMARKETING SURVEILLANCE; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; REVIEW; SURGICAL WOUND; WOUND CLOSURE;

EID: 0038207687     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1403.2003.03005.x     Document Type: Article

References (12)

1. Coombs DW, Saunders RL, Gaylor MS, Pageau M, Leith MG, Shaiberger C. Continuous epidural analgesia via implanted morphine reservoir. Lancet 1981;2:425-426.
2. Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981;56:516-520.
3. Coffey RJ, Cahill D, Steers W et al. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study. J Neurosurg 1993;78:226-232.
4. Naumann C, Erdine S, Koulousakis A, Van Buyten J-P, Schuchard M. Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management. Neuromodulation 1999;2:92-107.
5. Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 2000;19:209-215.
6. Krames ES, Chapple I. The 8703 W Catheter Study Group. Reliability and clinical utility of an implanted intraspinal catheter used in the treatment of spasticity and pain. Neuromodulation 2000;3:7-14.
7. Anonymous. Current trends in antibiotic prophylaxis in surgery. Surgery 2000;128 (Suppl.):S14-S18.
8. Haines SJ, Walters BC. Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis. Neurosurgery 1994;34:87-92.
9. Langley JM, LeBlanc JC, Drake J, Milner R. Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis 1993;17:98-103.
10. Kestle JR, Hoffman HJ, Soloniuk D, Humphreys RP, Drake JM, Hendrick EB. A concerted effort to prevent shunt infection. Childs Nerv Syst 1993;9:163-165.
11. Haughton VM. Spinal drug delivery: contrast media. In: Yaksh TL, ed. Spinal Drug Delivery. Amsterdam: Elsevier Science, 1999:531-542.
12. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection. a prospective study of risk factors. J Neurosurg 2001;94:195-201.